The Globe and Mail reports in its Tuesday, Feb. 27, edition that Raymond James analyst Michael Glen has reaffirmed his "strong buy" recommendation for 5N Plus. The Globe's David Leeder writes in the Eye On Equities column that Mr. Glen boosted his share target to $6 from $5. Analysts on average target the shares at $5.50. Mr. Glen says in a note: "We expect the biggest focal point for the 4Q result will be the 2024 and 2025 EBITDA guidance. Current 2024 EBITDA guidance is $45-million to $50-million (consensus $48.7-million) and we anticipate management will reiterate this outlook. We are anticipating that the company will introduce 2025 EBITDA guidance, and we are introducing our initial estimate of $55.8-million (inline with consensus with a range of $54.8-million to $57.1-million)." The Globe reported on Feb. 25, 2022, that Mr. Glen had trimmed his 5N Plus share target to $4 from $4.50, while maintaining an "outperform" recommendation. 5N Plus shares were then going for $2.25. The Globe reported on Oct. 27, 2023, that Mr. Glen had upgraded his recommendation for 5N Plus to "strong buy" from "outperform." His share target then was $5. 5N Plus shares could then be had for $3.22.